Observational studyIndian journal of pediatrics2026
Genetic Polymorphism in Febrile Seizures.
Observational study in Indian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the genetic polymorphisms associated with febrile seizures (FS) in children from Vijayapura District, Karnataka, South India. Also to identify novel or known pathogenic variants using whole exome sequencing (WES), explore clinical profiles, and assess associations with family or past history of FS.
methodsThis observational study included 50 children aged 6 mo to 6 y presenting with FS at Shri B.M. Patil Medical College, Vijayapura. After excluding those with neurological deficits or atypical seizure etiologies, peripheral blood samples were collected. DNA was extracted, and exon-specific primers were designed. PCR products were subjected to Sanger sequencing, and WES was performed on 12 cases. Clinical characteristics were recorded, and statistical analysis was done using SPSS v20.
resultsAmong 50 children, the most common age group was 1–2 y (50%), with males accounting for 56%. Family history and past history of FS were present in 38% and 40% respectively. Typical FS were more common (76%). WES revealed novel or rare variants, including variants of uncertain significance (VUS), in GABRG2, SEMA6B, and KCNQ2. While KCNQ2 (6%) and CPA6 (2%) pathogenic/likely pathogenic variants have known associations with FS, the SEMA6B variants observed (30%) are primarily VUS, and their functional or causal role in FS remains uncertain. No significant association was found between seizure type and family or past history.
conclusionsThis pilot study underscores the genetic heterogeneity of FS and identifies SEMA6B as a potentially relevant gene in South Indian children. WES may be a valuable tool for unraveling FS pathogenesis, especially in region-specific populations.
Indexed as
Identifiers
41758426What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.